Premium
P4–076: Immobilization of β–amyloid peptide on a chip and characterization of its interaction with proteins via atomic force microscopy and mass spectrometry
Author(s) -
Boussert Stéphanie
Publication year - 2006
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2006.05.1814
Subject(s) - peptide , chemistry , self assembled monolayer , monolayer , mass spectrometry , amyloid (mycology) , atomic force microscopy , amyloid precursor protein , biophysics , characterization (materials science) , colloidal gold , nanotechnology , chromatography , biochemistry , nanoparticle , materials science , alzheimer's disease , inorganic chemistry , biology , medicine , disease , pathology
by fibrillar A . To explore this possibility, primary rat astrocytes were used to test IDE levels after exposure to soluble or fibrillar A . After treatment with 5 M fibrillar A , IDE protein and transcripts increased 2-fold as detected by WB, immunofluorescence and RT-PCR compared to soluble A or control cultures. Conclusions: Our results suggest that the defective clearance of A due to IDE lower expression or activity is not an accelerating factor in Tg2576 mice amyloid deposition. Moreover, IDE overexpression associated to late-stages of the neuropathologic process in this animal model may be part of an inflammatory response, suggesting a new role for IDE in the brain that deserves future investigation.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom